I. Introduction

In the Philippines, the tax treatment of medicine purchases is often discussed in terms of VAT exemption, government procurement rules, senior citizen and PWD discounts, and the regulation of pharmaceutical prices and supply. Less appreciated, but equally important in day-to-day compliance, is the role of Expanded Withholding Tax (EWT) on payments made to medicine suppliers.

The central point is this: the purchase of medicines is not, by itself, what determines whether EWT applies. In Philippine tax law, EWT generally depends on the nature of the income payment, the status of the payor as a withholding agent, the classification of the transaction as goods or services, and the applicable BIR regulation covering that payment. A medicine purchase may therefore be subject to EWT in one setting, and not subject in another, even if the product involved is exactly the same.

This article explains the legal framework, the practical triggers, the special issues unique to pharmaceutical transactions, and the compliance consequences when EWT applies to suppliers of medicines in the Philippines.

II. Legal Nature of Expanded Withholding Tax

Expanded Withholding Tax is a form of creditable withholding tax under the National Internal Revenue Code and implementing regulations, principally the withholding tax rules under Section 57 and the regulations built around Revenue Regulations No. 2-98, as amended.

Unlike a final withholding tax, EWT is not the tax itself in final form. It is an advance collection mechanism. The buyer or payor withholds part of the payment due to the supplier and remits that amount to the Bureau of Internal Revenue. The supplier then treats the tax withheld as a credit against its income tax liability.

In practical terms:

the supplier earns the income from the sale;
the buyer, if required by law, withholds a portion of the payment;
the withheld amount is remitted to the BIR;
the supplier claims the amount withheld through the proper withholding tax certificate and tax return.

Thus, EWT is an income tax compliance mechanism, not a product tax. That distinction matters greatly in medicine purchases.

III. The Core Rule in Medicine Purchases

A. Medicine is not a special EWT category by itself

There is no general rule that says: “all medicine purchases are subject to EWT” or “all medicine purchases are exempt from EWT.”

The fact that the item sold is a medicine, drug, vaccine, pharmaceutical preparation, medical oxygen, or similar health product does not automatically control the withholding tax result.

The real questions are:

Is the buyer a withholding agent for that kind of payment?
Is the payment covered by the EWT rules on purchases of goods, services, or another income payment category?
Is the supplier a resident/local supplier whose income payment is subject to EWT?
Is there any specific exemption, special tax regime, or documentary basis removing the transaction from withholding?

B. The buyer’s status usually drives the analysis

In ordinary business, EWT on local purchases usually arises because the buyer belongs to a class of taxpayers required to withhold, such as:

government offices, agencies, instrumentalities, local government units, and certain government-owned or controlled corporations when making covered payments;
private entities specifically designated by the BIR as withholding agents, including Top Withholding Agents or other categories covered by revenue issuances;
persons making payments that fall under a specific withholding rule, even if the underlying item sold is medicine.

Therefore, if a private hospital, pharmacy chain, HMO, clinic network, or distributor buys medicines from a pharmaceutical company, wholesaler, or drug importer, EWT applies only if that buyer is legally required to withhold on that payment.

An ordinary private buyer not covered by the withholding rules does not withhold EWT merely because it purchased medicines.

IV. Why Medicine Transactions Often Create Confusion

Medicine purchases sit at the intersection of several tax concepts that are frequently mixed up:

A. VAT exemption is different from EWT

A medicine may be:

VAT-able,
VAT-exempt, or
sold under a transaction that carries special VAT consequences.

But VAT treatment does not automatically determine EWT treatment.

A supplier may sell VAT-exempt medicines and still be subject to EWT if the buyer is a withholding agent making a covered income payment. Conversely, a medicine sale may be subject to VAT but not subject to EWT if the buyer is not required to withhold.

This is one of the most common errors in practice: assuming that because certain medicines are VAT-exempt, they are also outside withholding tax. That is not the governing rule. VAT is a tax on the sale transaction; EWT is a creditable income tax collection mechanism on the supplier’s income.

B. “Medicines” may involve both goods and services

What appears to be a medicine purchase may in substance include:

outright sale of pharmaceutical products;
warehousing or cold-chain handling;
inventory management;
consignment administration;
promotional or marketing support;
training or product education;
logistics or delivery arrangements;
service fees embedded in the supply contract.

Where the transaction is mixed, the EWT analysis may differ by component. The goods portion and the service portion may not always follow the same rate or even the same withholding treatment.

V. When EWT Generally Applies to Suppliers of Medicines

A. Local purchase of medicines from resident suppliers by a withholding agent

The most common case is this:

a local supplier sells medicines in the Philippines;
the buyer is a government entity or a private entity required by the BIR to withhold;
the payment is for a covered purchase of goods from that local supplier.

In that situation, EWT generally applies.

For medicine transactions, the supplier may be:

a pharmaceutical manufacturer;
an importer-distributor;
a wholesaler;
a drug trader;
a hospital supplier;
a medical products company selling drugs and pharmaceutical items.

The key point is that the supplier is being paid income from a local sale, and the payor belongs to a category required to withhold.

B. Purchases by Top Withholding Agents

A significant number of medicine purchases in the private sector are made by large organizations such as:

major hospital groups;
national pharmacy chains;
integrated healthcare companies;
large corporations maintaining healthcare procurement systems.

Where such buyers are designated by the BIR as Top Withholding Agents or otherwise required to withhold on regular purchases from resident suppliers, payments for medicine purchases may be subject to EWT under the rules on purchases of goods.

Here, the product being sold remains medicine, but what triggers withholding is the buyer’s status as a withholding agent under the BIR rules.

C. Government procurement of medicines

Government purchases of medicines are a major area of withholding compliance. National government agencies, government hospitals, local government units, and other public entities purchasing medicines from suppliers generally operate under specific withholding obligations.

In government procurement, separate tax concepts may run side by side:

EWT on the supplier’s income, and
VAT-related withholding rules, where applicable.

These are not interchangeable. A government buyer may have to consider both, depending on the nature of the transaction and the tax status of the supplier.

VI. When EWT Does Not Automatically Apply

A. Purchase by a non-withholding private buyer

If a private clinic, small pharmacy, medical practice, or business is not covered as a withholding agent for that payment, its purchase of medicines from a supplier does not become subject to EWT simply because the seller is a corporation or because the purchase is for business use.

The buyer must have a legal withholding obligation. Without that, the payment is made in full, subject to any other applicable tax rules.

B. Importation from a foreign seller is not the same as a local supplier payment

If medicines are sourced from a nonresident foreign seller, the transaction is not usually analyzed as a routine EWT on payment to a local resident supplier. Instead, the tax issues may shift to:

customs duties and import VAT, where applicable;
withholding on related payments such as commissions, royalties, technical assistance fees, freight, or other cross-border income streams;
treaty issues, if relevant.

A direct importation of medicines is therefore not the same as a local purchase from a Philippine resident distributor.

C. Transactions covered by valid exemption or special treatment

A supplier may have a specific basis for non-withholding, such as:

a valid BIR-issued tax exemption or ruling covering the income;
a special tax regime where the income is not subject to ordinary creditable withholding in the same manner;
documentary proof recognized by law or regulation.

Without proper documentary basis, however, a buyer should not casually assume that a medicine supplier is exempt from EWT.

VII. Classification Matters: Goods, Services, or Mixed Transactions

Medicine procurement contracts are often drafted loosely. That creates tax risk.

A. Pure sale of goods

If the supplier simply sells medicines as inventory or pharmaceutical goods, the transaction is generally treated as a purchase of goods. If the buyer is a withholding agent, the applicable EWT rule for purchases of goods from resident suppliers is normally used.

B. Sale with service components

If the contract includes services such as:

inventory monitoring;
dispensing support;
product management;
warehousing service;
delivery service billed separately;
implementation fees;
technical support or training;
promotional detailing or marketing support,

the service component may attract a different withholding rule.

A common compliance mistake is withholding one rate across the entire invoice without checking whether part of the billing is really for services.

C. Bundled or package arrangements

Where medicines are bundled with equipment, consumables, software, training, or support arrangements, the transaction should be reviewed carefully. If separable, the safer approach is often to segregate:

medicine/goods component;
equipment component;
service component.

This reduces the risk of applying the wrong withholding treatment.

VIII. The Withholding Base in Medicine Purchases

Even when EWT applies, the next issue is the amount on which it is computed.

A. VAT-exclusive base where VAT is separately indicated

As a rule in withholding tax practice, where the supplier is VAT-registered and the VAT component is separately stated, the withholding base for EWT is generally the income payment exclusive of VAT.

Thus, for a VAT-able medicine sale with a properly stated VAT component, the buyer withholds on the net selling price, not on the VAT.

B. Full amount if the sale is VAT-exempt

Where the medicine sale is VAT-exempt, there is no output VAT component to strip out. In that case, the withholding base is generally the full income payment actually payable, subject to lawful adjustments such as discounts, returns, and credit memos.

This is one reason VAT exemption on medicines does not eliminate EWT; it may simply change the withholding base.

C. Discounts mandated by law

For medicines sold with legally mandated benefits, particularly to senior citizens or persons with disability, the computation must reflect the amount that is legally due and payable after the required discount and VAT treatment.

The practical rule is that withholding should follow the actual taxable income payment to the supplier, not an inflated gross amount that the supplier is not legally entitled to collect.

D. Returns, replacements, expiries, and rebates

Medicine transactions commonly involve:

product returns;
replacement of damaged items;
pull-outs of expired products;
volume rebates;
year-end incentives;
chargebacks and debit-credit note arrangements.

These matter because EWT should correspond to actual income ultimately earned. If the adjustment is known before payment, withholding should be based on the net amount. If adjustments happen later, the parties must reconcile records carefully so the supplier does not end up with excess or unsupported withholding credits.

IX. Applicable Rates: A Note of Caution

The applicable EWT rate for purchases from suppliers has been revised by revenue issuances over time. In medicine procurement, the rate depends not on the fact that the product is medicine, but on the withholding category that governs the payment, such as:

purchase of goods from resident suppliers,
payment for services,
or another specific income payment classification.

Because withholding rates have been amended more than once, the correct legal approach is to identify:

the current category applicable to the payment,
the status of the buyer as withholding agent,
the precise transaction date,
and the revenue regulation then in force.

In short, one should not assume a fixed rate for all medicine purchases across all periods.

X. Documentation and Compliance Duties

When EWT applies to medicine suppliers, compliance is not complete upon mere deduction from payment.

A. Duties of the buyer/payor

The buyer must:

determine whether it is required to withhold;
apply the correct rate and base;
remit the tax withheld within the proper deadlines;
issue the proper Certificate of Creditable Tax Withheld at Source to the supplier;
reflect the transaction correctly in its withholding tax returns and books.

The certificate is critical because it is the supplier’s documentary basis for claiming the tax credit.

B. Duties of the supplier

The medicine supplier must:

reconcile sales invoices and official billing documents with amounts withheld;
ensure that withholding certificates match actual collections and taxable periods;
claim the withheld amount as a credit in the proper tax return;
monitor discrepancies, especially in high-volume hospital and pharmacy accounts.

Suppliers that deal with multiple government hospitals or large private buyers often accumulate significant withholding credits. Poor reconciliation can lead to denied or unusable credits.

XI. Consequences of Wrong Withholding

Improper handling of EWT in medicine purchases can create exposure for both sides.

A. For the buyer

A buyer that fails to withhold, under-withholds, or remits late may face:

deficiency withholding tax assessments;
surcharges and interest;
compromise penalties;
administrative difficulties in procurement and audit.

B. For the supplier

The supplier may face:

cash flow loss if excess tax is withheld;
inability to claim tax credits due to missing or defective certificates;
mismatch issues during BIR audit;
disputes with customers over net payment and tax treatment.

In medicine distribution, where margins may already be compressed by discount regulations, reimbursement terms, and procurement competition, withholding errors can have substantial financial impact.

XII. Practical Philippine Scenarios

A. Drug manufacturer selling to a private hospital chain

If the hospital chain is a BIR-designated withholding agent and the transaction is a local purchase of medicines from a resident supplier, EWT generally applies under the rules for purchases of goods.

B. Small clinic buying from a neighborhood pharmacy distributor

If the clinic is not a withholding agent for that payment, no EWT is ordinarily withheld merely because the item purchased is medicine.

C. Government hospital procuring antibiotics from a local distributor

The government hospital generally has withholding obligations. EWT on the supplier’s income may apply, alongside other tax withholding rules relevant to government payments.

D. Hospital contract covering medicines plus inventory management service

The medicine component and service component should be analyzed separately if the billing structure or contract supports segregation. One withholding category may apply to the goods, and another to the services.

E. Sale of VAT-exempt medicines to a pharmacy chain that is a withholding agent

The sale may still be subject to EWT. The absence of VAT does not eliminate the withholding obligation if the payment is a covered income payment to a supplier.

XIII. Key Legal Conclusions

Medicine purchases are not automatically subject to EWT. The nature of the item as medicine is not, by itself, the legal trigger.
EWT usually depends on the buyer’s status as a withholding agent and the kind of income payment being made.
VAT exemption of medicines does not by itself exempt the transaction from EWT. VAT and EWT serve different tax functions.
The sale of medicines as goods is treated differently from service components embedded in supply contracts. Proper classification matters.
Government procurement of medicines commonly involves withholding obligations. Private transactions do only when the buyer is covered by withholding rules.
The correct withholding base must reflect the actual income payment, taking into account VAT treatment, lawful discounts, returns, rebates, and credit adjustments.
Rates must be checked against the applicable revenue issuance in force for the transaction period. They have changed over time.
Documentation is essential. Without proper withholding certificates and reconciliation, suppliers may lose tax credits or face audit issues.

XIV. Final View

In Philippine tax law, Expanded Withholding Tax on medicine purchases is fundamentally a rule about the payor and the payment, not about medicine as a product category. A pharmaceutical supplier becomes subject to EWT when it receives a covered income payment from a buyer that is legally required to withhold under the National Internal Revenue Code and the applicable BIR regulations. The analysis then turns to the classification of the transaction, the status of the supplier, the treatment of VAT and discounts, and the exact withholding rule in force at the time of payment.

For that reason, the legally correct question is not, “Are medicines subject to EWT?” The correct question is:

“When a Philippine buyer pays a medicine supplier, is that buyer required to withhold EWT on that income payment under the applicable withholding tax rules?”

That is the question that decides the result.